Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Messina

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Tumori|June 6, 2015
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case reportCarlo Messina, Antonio Di Meglio, Pier Vitale Nuzzo, et al.
European Journal of Clinical Investigation|December 31, 2020
Efficacy and safety of PD1/PDL1 blockade with platinum-based chemotherapy for extensive small cell lung cancer: A pooled analysis of randomized trialsCarlo Messina, Massimiliano Salati, Marco Messina, et al.
Critical Reviews in Oncology/Hematology|October 9, 2021
Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical reviewOrazio Caffo, Marco Messina, Antonello Veccia, et al.
Anti-Cancer Drugs|July 30, 2019
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experienceGiacomo Vallome, Carlo Cattrini, Carlo Messina, et al.
Cancer Treatment Reviews|February 21, 2015
Primary and secondary bone lymphomasCarlo Messina, David Christie, Emanuele Zucca, et al.
Tumori|September 30, 2015
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case reportCarlo Messina, Antonio Di Meglio, Pier Vitale Nuzzo, et al.
La Radiologia Medica|April 6, 2018
Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectivesGiuseppe Badalamenti, Carlo Messina, Ida De Luca, et al.
International Journal of Cancer|August 17, 2022
Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)"Carlo Cattrini, Carlo Messina, Alessia Mennitto, et al.
JCO Oncology Practice|December 22, 2020
Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution ExperienceValeria Merz, Antonella Ferro, Enrico Maria Piras, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 2, 2024
Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment: Still the era of microsatellites?Mauro Francesco Pio Maiorano, Carlo Messina, Evaristo Maiello, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Tumori|June 6, 2015
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case reportCarlo Messina, Antonio Di Meglio, Pier Vitale Nuzzo, et al.
European Journal of Clinical Investigation|December 31, 2020
Efficacy and safety of PD1/PDL1 blockade with platinum-based chemotherapy for extensive small cell lung cancer: A pooled analysis of randomized trialsCarlo Messina, Massimiliano Salati, Marco Messina, et al.
Critical Reviews in Oncology/Hematology|October 9, 2021
Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical reviewOrazio Caffo, Marco Messina, Antonello Veccia, et al.
Anti-Cancer Drugs|July 30, 2019
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experienceGiacomo Vallome, Carlo Cattrini, Carlo Messina, et al.
Cancer Treatment Reviews|February 21, 2015
Primary and secondary bone lymphomasCarlo Messina, David Christie, Emanuele Zucca, et al.
Tumori|September 30, 2015
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case reportCarlo Messina, Antonio Di Meglio, Pier Vitale Nuzzo, et al.
La Radiologia Medica|April 6, 2018
Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectivesGiuseppe Badalamenti, Carlo Messina, Ida De Luca, et al.
International Journal of Cancer|August 17, 2022
Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)"Carlo Cattrini, Carlo Messina, Alessia Mennitto, et al.
JCO Oncology Practice|December 22, 2020
Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution ExperienceValeria Merz, Antonella Ferro, Enrico Maria Piras, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 2, 2024
Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment: Still the era of microsatellites?Mauro Francesco Pio Maiorano, Carlo Messina, Evaristo Maiello, et al.
Pageof 11